SOURCE: Regenerative Medicine Foundation

Regenerative Medicine Foundation

February 23, 2011 17:01 ET

John Bardis to Speak at 2011 Translational Regenerative Medicine Forum

WINSTON-SALEM, NC--(Marketwire - February 23, 2011) - The Regenerative Medicine Foundation today announced that John Bardis, founder of MedAssets, will be a keynote speaker at the 2011 Translational Regenerative Medicine Forum, taking place April 6-8 at the Ronald Reagan Building and International Trade Center in Washington, DC.

Bardis has acted as chairman, president, and chief executive officer of MedAssets since its inception and has held senior management positions at companies including Baxter, Kinetic Concepts, and Theratx. At the Forum, he will share his expertise on supply chain issues, data requirements, and other obstacles and associated costs that challenge the commercialization of regenerative medicine treatments.

"With over 25 years of experience in the health care industry, John Bardis is a great addition to the incredible lineup of speakers we have for the 2011 Translational Regenerative Medicine Forum. We are very excited to share his knowledge and best practices with the regenerative medicine community," said DaLaura L.S. Kader, LLB, Vice President of Strategic Initiatives at the Foundation.

The Translational Regenerative Medicine Forum is an international event convening members of the academic, clinical, pharmaceutical, government, and venture capitalist community to collaborate and advance the science of regenerative medicine. To access the full agenda and to register for the Forum, please visit or call 866-831-3244.

About the Regenerative Medicine Foundation
The Regenerative Medicine Foundation
(, launched in 2005, is an internationally-focused, not-for-profit organization created to enable the advancement of new treatments and therapies based on regenerative medicine, and ultimately, to realize the goals of personalized medicine.

Through educational programs, translational conferences and public policy initiatives, the Foundation advocates for increased medical research, promotes the training and education of scientists, and facilitates the translation of therapies to patients.

About MedAssets
(NASDAQ: MDAS) partners with healthcare providers to improve financial strength by implementing spend management and revenue cycle management solutions that help control cost, improve margins and cash flow, increase regulatory compliance and optimize operational efficiency. MedAssets serves more than 180 health systems, 4,000 hospitals and 75,000 non-acute healthcare providers. For more information, go to

Contact Information

  • Media Contact:
    Nicolle Kaufmann
    Media Manager
    Email Contact